Please assess the completion status of the following clinical trial:

Trial Title: Clinical Assessment of a HYDRAGLYDE® Regimen

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Must sign informed consent document;~* Vision correctable to 0.1 (LogMAR) or better in each eye at distance with habitual lenses;~* Manifest cylinder (at screening) less than or equal to 0.75 diopter (D) in each eye and spectacle add \<+0.50 D in each eye;~* Current full-time wearer of spherical samfilcon A, comfilcon A, senofilcon C monthly or senofilcon A 2-week replacement lens within the power range of lens powers available;~* Current user of an MPS (excluding OFPM) to care for lenses;~* Willing to answer text messages on a daily basis during the study;~* Willing to discontinue artificial tears during the study and rewetting drops on the days of study visits;~* Use of digital devices (eg, smart phone, tablet, laptop or desktop computer) for 20 consecutive minutes at least twice a week and willing to continue for the duration of the study;~* Other protocol specific inclusion criteria may apply.~Exclusion Criteria:~* Habitual lens wear in an extended wear modality (routinely sleeping in lenses overnight for 1 or more nights per week);~* Any anterior segment infection, inflammation, disease or abnormality that contraindicates contact lens wear;~* History of herpetic keratitis, corneal surgery or irregular cornea;~* Prior refractive surgery;~* Any use of systemic or ocular medications for which contact lens wear could be contraindicated as determined by the investigator;~* Currently using or have not discontinued Restasis®, Xiidra™ and/or topical steroids within the past 7 days;~* Use of mechanical eyelid therapy or eyelid scrubs within 14 days before Visit 1 and not willing to discontinue during the study;~* Monocular (only 1 eye with functional vision) or fit with only 1 lens;~* Known pregnancy or lactating;~* Other protocol specific exclusion criteria may apply.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- AOHG (Type: EXPERIMENTAL): Lotrafilcon B contact lenses with added wetting agent, worn bilaterally (in both eyes) for 30 days in a daily wear modality and cared for with either a hydrogen peroxide-based contact lens solution with added wetting agent or a POLYQUAD/ALDOX-preserved contact lens solution with added wetting agent, as randomized
- Habitual (Type: ACTIVE_COMPARATOR): Habitual silicone hydrogel contact lenses worn bilaterally for 30 days in a daily wear modality and cared for with participant's habitual multi-purpose solution (MPS)

Based on this trial design, predict the completion outcome and termination type (if applicable).